Asthma Flashcards

1
Q

asthma

A

reversible, often intermittent, obstructive disease or the small airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pathophysiology of asthma

A

airway inflammation, airway hyperactivity, bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what type of hypersensitivity reaction is asthma

A

type 1 hypersensitivity rxn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RF for asthma

A

atopy strongest risk factor
FHx
pollution
obesity
environmental tobacco smoke
male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sx asthma

A

episodic dyspnea
wheezing
cough (especially at night)
may have chest tightness or fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PE for asthma

A

wheezing and/or prolonged expiratory phase during normal breathing due to presence of airflow obstruction, hyper resonance to percussion, decreased breath sounds, tachycardia, tachypnea, use of accessory muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

when is wheezing most prominent in asthma

A

during expiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

severe asthma and status asthmaticus

A

inability to speak ion full sentences, “tripod” positioning, silent chest, altered mental status, pulses paradoxes (inspiratory BP drop > 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the best and most objective way to assess acute exacerbation severity and patient response to tx in asthma

A

peak expiratory flow rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what percent for peak expiroatry flow rate indicates tx response in asthma

A

PEFR > 15%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what PEFR value indicates respiratory distress in asthma

A

PEFR < 200 L/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what might ABG show during mild exacerbation

A

respiratory alkalosis from tachypnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what indicates need for mechanical ventilation in asthma

A

pseudo normalization of the PaCO2 or the combination of an increased PaCO2 and respiratory acidosis may indicate impending respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

are chest radiographs helpful in the diagnosis of asthma

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

airflow obstruction in asthma

A

decreased FEV1
Decreased FEV1/FVC <0.7
increased lung volumes due to hyperinflation: increased residual volume (RV), total lung capacity (TLC), and RV/TLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

significant reversibility in asthma

A

increase in 12% or more and 200 mL in FEV1 or FVC after inhaling a short-acting bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what test can you do for asthma when asthma is suspected but baseline spirometry is normal or non diagnostic

A

bronchial provocation with Methacholine or Histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what will bronchial provocation testing show for asthma

A

a decrease in FEV1 20% or greater after exposure to methacholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

intermittent asthma

A

sx 2 or fewer times per week
2 or fewer awakenings due to sx per month
use of SABA two or fewer times per week
no interference with normal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

tx for intermittent asthma

A

short-acting beta-agonist as needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

mild persistent asthma

A

sx > 2 times per week (but not daily)
3-4 episodes of night awakenings due to sx per month
use of SABA more than 2 times per week (but not daily and not more than once per day)
minor limitations to daily activity

22
Q

tx for mild persistent asthma

A

low dose inhaled corticosteroids
short acting beta agonist as needed

23
Q

moderate persistent asthma

A

sx daily
night awakenings due to sx at least once per week (but not nightly)
use of SABA on daily basis
some limitations in daily activity

24
Q

tx moderate persistent asthma

A

low dose inhaled corticosteroids plus long acting beta agonist or a medium dose inhaled corticosteroid plus a long acting beta agonist
short acting beta agonist as needed

25
Q

severe persistant asthma

A

sx daily
night awakenings every night
use of SABA multiple times per day
extreme limitations in daily activity

26
Q

tx severe persistent asthma

A

medium or high dose inhaled corticosteroid and a long-acting beta agonist plus LAMA and oral system corticosteroids

27
Q

short acting beta agonists

A

albuterol
levalbuterol
Terbutaline
Epinephrine

28
Q

ADE short acting beta agonists

A

tachycardia
arrhythmias
muscle tremors
CNS stimulation
hypokalemia

29
Q

anticholinergics (SAMA/LAMA)

A

Ipratropium
Aclidinium
Glycopyrrolate
Revefenacin
Tiotropium
Umeclidinium

30
Q

anticholinergics ADE

A

thirst
blurred vision (pupil dilation)
dry mouth
urinary retention
dysphagia
glaucoma
BPH

31
Q

corticosteroids

A

Prednisone
Methylprednisolone
Prednisolone

32
Q

ADE corticosteroids

A

immunosuppression
catabolic
hyperglycemia
fluid retention
osteoporosis
growth delays

33
Q

inhaled corticosteroids

A

beclomethasone
Flunisolide
Triamcinolone

34
Q

ADE inhaled corticosteroids

A

oral candidiasis
dysphonia

35
Q

long acting beta agonists

A

Salmeterol
ICS/LABA: Budesonide/Formoterol, Fluticasone/Salmeterol

36
Q

mast cell modifiers

A

Cromolyn
Nedocromil

minimal side effects

37
Q

Leukotriene modifiers/receptor antagonists

A

Montelukast
Zafirlukast
Zileuton

minimal side effects

38
Q

ADE Theophylline

A

nervousness
N/V
Anorexia
HA
Narrow TI: toxicity causes arrhythmias and seizures

39
Q

acute bronchitis

A

self-limited lower respiratory tract infection causing inflammation of the large airways

40
Q

most common cause of acute bronchitis

A

respiratory virus - Influenza A and B, parainfluenza virus, respiratory syncytial virus, coronavirus, adenovirus, rhinovirus

41
Q

bacterial causes of acute bronchitis

A

s pneumonia
h influenza
m catarrhalis
mycoplasma pneumoniae
chalmydia pneumoniae
bordetella pertussis

42
Q

when does acute bronchitis commonly occur

A

during winter months

43
Q

sx acute bronchitis

A

cough is hallmark - acute and persistent (1-3 weeks); initially nonproductive but later a productive cough with sputum may develop. presence of sputum is nonspecific.

URI sx - runny nose, sore throat, low grade fever, malaise, sore throat, HA, myalgias, fever — fever is rare in acute bronchitis

wheezing or mild dyspnea

44
Q

PE for acute bronchitis

A

often normal but both wheezing and honcho may be auscultated on PE
honcho usually clear with coughing

45
Q

dx acute bronchitis

A

clinical - acute onset of persistent cough (1-3 weeks) + no findings suggestive of pneumonia (fever, tachypnea, rales, hypoxia, or signs of parenchymal consolidation, such as dullness to percussion, decreased or bronchial breath sounds, rales, ego phony)

46
Q

chest radiographs for acute bronchitis

A

not needed - usually normal or nonspecific.
indicated when acute bronchitis cannot be distinguished from pneumonia

47
Q

tx acute bronchitis

A

self limited

48
Q

tx for cough in bronchitis

A

guaifenasin
dextromethorphan
benzonatate
codeine

49
Q

FEV1 and FCV for intermittent asthma

A

FEV1 > 80% of predicted
normal FEV1/FVC

50
Q

FEV1 and FVC in mild persistent asthma

A

FEV1 > 80% predicted
normal FEV1/FVC

51
Q

FEV1 and FVC in moderate persistent asthma

A

FEV1 60-80% predicted
FEV1/FVC reduced by < 5%

52
Q

FEV1 and FVC in severe persistent asthma

A

FEV1 < 60
FEV1/FVC reduced by > 5%